Watch our most recent webinar

resisttb
Sep 30, 2021
1 min read

On Thursday, September 23rd RESIST-TB hosted this webinar webinar featuring Dr. Keertan Dheda, who will present the results of the recently-completed NeXT clinical trial for MDR-TB. This study evaluated the impact of a new injection-free six-to-nine month treatment regimen of linezolid, bedaquiline, levofloxacin, pyrazinamide (PZA) and ethionamide/high dose isoniazid (INH) compared to the conventional empiric injection-based regimen. Read more here.

Watch Webinar Here!

Password: RESIST1@

Recent Posts

See All

International Course on the Clinical and Programmatic Management of DRTB

In person in Taipei in October 2025, by Prof Chen-Yuan Chiang. This course is essential for staff from National TB Programmes in charge...

USAid cuts could create untreatable TB bug ‘resistant to everything we have’

The Stop TB Partnership has raised alarms for the potential for new TB mutations associated with interruptions in care. The COVID...

World Health Organization warns of possible tuberculosis surge because of USAID cuts

A recent statement from the WHO warned of a spike in tuberculosis as a result of the shuttering of USAID. This trend can already be seen...

Watch Webinar Here!

Password: RESIST1@

Comments